Advances in Biomedical Measurement Science

The Advances in Biomedical Measurement Science (ABMS) program supports research to provide significant improvements in the accuracy and comparability of vital data used to make important research, regulatory, clinical, and manufacturing quality control decisions. The program is co-led by Stanford University (SU) and the National Institute for Standards and Technology (NIST). The goals of the ABMS program are to greatly reduce the time for translation of new technology and new drugs into clinical practice, increase safety and efficacy of new pharmaceuticals, as well as greatly decrease the regulatory burden of introducing the next generation of innovative instruments, standardized reagents, protocols, and computational tools needed to improve patient outcomes and reduce healthcare costs.